DexCom Inc (NAS:DXCM)
$ 80.24 0.7 (0.88%) Market Cap: 31.07 Bil Enterprise Value: 31.36 Bil PE Ratio: 47.63 PB Ratio: 15.70 GF Score: 79/100

Q1 2021 Dexcom Inc Earnings Call Transcript

Apr 29, 2021 / 08:30PM GMT
Release Date Price: $105.43 (-0.96%)
Operator

Welcome to the DexCom First Quarter 2021 Earnings Release Conference Call. My name is Adrian, and I'll be your operator for today's call. (Operator Instructions) Please note this conference is being recorded.

I'll now turn the call over to Sean Christensen. Sean, you may begin.

Sean Christensen
DexCom, Inc. - Director of Corporate Affairs & Head of IR

Thank you, operator, and good afternoon, everyone. Welcome to DexCom's First Quarter 2021 Earnings Call. Our agenda begins with Kevin Sayer, DexCom's Chairman, President and CEO, who will provide a summary of our progress; followed by a financial review and outlook from Jereme Sylvain, our Chief Financial Officer; and then an update from Quentin Blackford, our Chief Operating Officer, on the company's strategic initiatives and scaling progress. (Operator Instructions) Please note that there are also slides available related to our first quarter performance on the DexCom Investor Relations website on the Events and Presentations page. With that, let's review our safe harbor statement.

Some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot